Spinal Cord Stimulation Holds Promise for Chronic Pain
WEDNESDAY, Nov. 20, 2024 -- Spinal cord stimulation (SCS) for treatment of chronic pain in the back and/or lower extremities is associated with greater improvements in pain compared with conventional medical management (CMM), according to a review published online Nov. 14 in JAMA Network Open.
Frank J. P. M. Huygen, Ph.D., M.D., from Erasmus Medical Center in Rotterdam, Netherlands, and colleagues conducted a systematic literature review and network meta-analysis to evaluate the efficacy of SCS therapies compared to CMM.
Based on 13 included studies (1,561 patients), the researchers found that both conventional and novel SCS therapies were associated with superior efficacy versus CMM in responder rates for pain reduction in the back (conventional SCS: odds ratio [OR], 3.00; novel SCS: OR, 8.76), pain intensity in the back (conventional SCS: mean difference [MD], −1.17; novel SCS: MD, −2.34), pain intensity in the leg (conventional SCS: MD, −2.89; novel SCS: MD, −4.01), and the EQ-5D index score (conventional SCS: MD, 0.15; novel SCS: MD, 0.17). Conventional SCS was superior to CMM for functional disability (MD, −7.10).
"Our study provides important insights for clinical decision-making as well as assessment by health technology agencies based on a more representative evidence base and a more inclusive analytical framework than that reported by prior reviews comparing SCS technologies," the authors write.
Several authors disclosed ties to Medtronic.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Timely Opioid Administration Cuts Hospitalizations for Pediatric Sickle Cell Crises
WEDNESDAY, Sept. 10, 2025 -- Providing timely pain relief may reduce chances of hospitalization for children presenting to the emergency department with a sickle cell crisis...
Severely Injured Trauma Patients Are Undertriaged at Nontrauma Centers
WEDNESDAY, Sept. 10, 2025 -- More than half of severely injured trauma patients first treated at level III or nontrauma centers are not transferred to higher-level trauma centers...
Discontinuation of Medical Cannabis Common in Musculoskeletal Pain
TUESDAY, Aug. 26, 2025 -- A number of patients with musculoskeletal pain discontinue medical cannabis (MC) within one year, with many discontinuing within the first three months...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.